Acute Lung Injury Induced by Lipopolysaccharide Is Independent of Complement Activation1

Although acute lung injury (ALI) is an important problem in humans, its pathogenesis is poorly understood. Airway instillation of bacterial LPS, a known complement activator, represents a frequently used model of ALI. In the present study, pathways in the immunopathogenesis of ALI were evaluated. ALI was induced in wild-type, C3−/−, and C5−/− mice by airway deposition of LPS. To assess the relevant inflammatory mediators, bronchoalveolar lavage fluids were evaluated by ELISA analyses and various neutralizing Abs and receptor antagonists were administered in vivo. LPS-induced ALI was neutrophil-dependent, but it was not associated with generation of C5a in the lung and was independent of C3, C5, or C5a. Instead, LPS injury was associated with robust generation of macrophage migration inhibitory factor (MIF), leukotriene B4 (LTB4), and high mobility group box 1 protein (HMGB1) and required engagement of receptors for both MIF and LTB4. Neutralization of MIF or blockade of the MIF receptor and/or LTB4 receptor resulted in protection from LPS-induced ALI. These findings indicate that the MIF and LTB4 mediator pathways are involved in the immunopathogenesis of LPS-induced experimental ALI. Most strikingly, complement activation does not contribute to the development of ALI in the LPS model.

[1]  S. Nourshargh,et al.  Role of neutrophil elastase in LTB4‐induced neutrophil transmigration in vivo assessed with a specific inhibitor and neutrophil elastase deficient mice , 2007, British journal of pharmacology.

[2]  D. A. Schwartz,et al.  Complement levels and activity in the normal and LPS-injured lung. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[3]  D. Ray,et al.  Human Macrophage Migration Inhibitory Factor , 2006, Journal of Biological Chemistry.

[4]  John D Lambris,et al.  Generation of C5a in the absence of C3: a new complement activation pathway , 2006, Nature Medicine.

[5]  K. Ley,et al.  Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung. , 2006, The Journal of clinical investigation.

[6]  R. Bucala,et al.  Macrophage migration inhibitory factor. , 2005, Critical care medicine.

[7]  K. Ley,et al.  Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[8]  J. Younger,et al.  HARMFUL AND PROTECTIVE ROLES OF NEUTROPHILS IN SEPSIS , 2005, Shock.

[9]  Takashi Yamamoto,et al.  Expression of toll-like receptor 2 and 4 in lipopolysaccharide-induced lung injury in mouse , 2005, Cell and Tissue Research.

[10]  John D Lambris,et al.  Complement Component C5a Is Integral to the Febrile Response of Mice to Lipopolysaccharide , 2005, Neuroimmunomodulation.

[11]  J. V. Sarma,et al.  Relationship of acute lung inflammatory injury to Fas/FasL system. , 2005, The American journal of pathology.

[12]  J. V. Sarma,et al.  Novel chemokine responsiveness and mobilization of neutrophils during sepsis. , 2004, The American journal of pathology.

[13]  H. You,et al.  Transepithelial Migration of Neutrophils in Response to Leukotriene B4 Is Mediated by a Reactive Oxygen Species-Extracellular Signal-Regulated Kinase-Linked Cascade 1 , 2003, The Journal of Immunology.

[14]  W. Seeger,et al.  Distinct pathways of lipopolysaccharide priming of human neutrophil respiratory burst: Role of lipid mediator synthesis and sensitivity to interleukin-10 , 2002, Critical care medicine.

[15]  D. Carter,et al.  Characterization of a Murine Model of Endotoxin-Induced Acute Lung Injury , 2002, Shock.

[16]  T. Calandra,et al.  MIF regulates innate immune responses through modulation of Toll-like receptor 4 , 2001, Nature.

[17]  W. Watford,et al.  Surfactant Protein A Regulates Complement Activation1 , 2001, The Journal of Immunology.

[18]  J. Younger,et al.  Protective effects of anti‐C5a peptide antibodies in experimental sepsis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  W. Watford,et al.  Complement-mediated host defense in the lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[20]  J. Nishihira,et al.  Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[21]  R. Medzhitov,et al.  Innate immune recognition: mechanisms and pathways , 2000, Immunological reviews.

[22]  T. Shimizu,et al.  An in vivo approach showing the chemotactic activity of leukotriene B(4) in acute renal ischemic-reperfusion injury. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  H. Colten,et al.  Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. , 1999, Immunopharmacology.

[24]  H. Makita,et al.  Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation. , 1998, American journal of respiratory and critical care medicine.

[25]  F. Saulnier,et al.  Bronchial neutrophilia in patients with noninfectious status asthmaticus. , 1998, American journal of respiratory and critical care medicine.

[26]  J. Murrow,et al.  Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. , 1997, Journal of immunology.

[27]  D. Remick,et al.  Regulatory effects of interleukin-6 in immunoglobulin G immune-complex-induced lung injury. , 1997, The American journal of pathology.

[28]  J. Pittet,et al.  Biological markers of acute lung injury: prognostic and pathogenetic significance. , 1997, American journal of respiratory and critical care medicine.

[29]  G. Raghu,et al.  Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome. , 1997, American journal of respiratory and critical care medicine.

[30]  R. Bucala,et al.  Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome , 1997, Nature Medicine.

[31]  P. Ward,et al.  Rous-Whipple Award Lecture. Role of complement in lung inflammatory injury. , 1996, The American journal of pathology.

[32]  P. Ward,et al.  Requirement and role of C5a in acute lung inflammatory injury in rats. , 1996, The Journal of clinical investigation.

[33]  P. Barton,et al.  Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock , 1993, Infection and immunity.

[34]  W. Seeger,et al.  Alveolar surfactant and adult respiratory distress syndrome , 1993, The clinical investigator.

[35]  J. Kelley.  Cytokines of the lung. , 1992, The American review of respiratory disease.

[36]  G. Feuerstein,et al.  Role of complement in endotoxin/platelet-activating factor-induced lung injury. , 1992, Journal of immunology.

[37]  I. Morita,et al.  Priming effects of leukotriene B4 on endothelial cell injury induced by tpa-activated leukocytes , 1992, Inflammation.

[38]  W. Johnson,et al.  Legionella pneumophila lipopolysaccharide activates the classical complement pathway , 1992, Infection and immunity.

[39]  D. Remick,et al.  Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. , 1989, The Journal of clinical investigation.

[40]  E. Chi,et al.  Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. , 1989, The Journal of clinical investigation.

[41]  A. Schmaier,et al.  Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome. , 1988, The Journal of laboratory and clinical medicine.

[42]  R. Strunk,et al.  Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. , 1988, The Journal of clinical investigation.

[43]  A. Falus,et al.  The fifth component of complement (C5) in the mouse. Analysis of the molecular basis for deficiency , 1987, The Journal of experimental medicine.

[44]  D. Morrison,et al.  Activation of human serum complement by bacterial lipopolysaccharides: structural requirements for antibody independent activation of the classical and alternative pathways. , 1987, Molecular immunology.

[45]  G. Hetland,et al.  Human Alveolar Macrophages Synthesize the Functional Alternative Pathway of Complement and Active C5 and C9 in Vitro , 1986, Scandinavian journal of immunology.

[46]  P. Parsons,et al.  Chemotactic activity in bronchoalveolar lavage fluid from patients with adult respiratory distress syndrome. , 1985, American Review of Respiratory Disease.

[47]  J. Solomkin,et al.  Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man. , 1985, Surgery.

[48]  M. J. Smith,et al.  The stimulation of lysosomal enzyme secretion from human polymorphonuclear leucocytes by leukotriene B4 , 1981, The Journal of pharmacy and pharmacology.

[49]  L. J. Weaver,et al.  ASSOCIATION OF COMPLEMENT ACTIVATION AND ELEVATED PLASMA-C5a WITH ADULT RESPIRATORY DISTRESS SYNDROME Pathophysiological Relevance and Possible Prognostic Value , 1980, The Lancet.

[50]  P. Ward,et al.  Acute immunologic pulmonary alveolitis. , 1974, The Journal of clinical investigation.

[51]  E. Gelfand,et al.  Role of the LTB4/BLT1 pathway in allergen-induced airway hyperresponsiveness and inflammation. , 2006, Allergology international : official journal of the Japanese Society of Allergology.

[52]  M. Pollack,et al.  Antibacterial and protective properties of monoclonal antibodies reactive with Escherichia coli O111:B4 lipopolysaccharide: relation to antibody isotype and complement-fixing activity. , 1992, The Journal of infectious diseases.

[53]  R. Burrell,et al.  Mediators of pulmonary injury induced by inhalation of bacterial endotoxin. , 1988, The American review of respiratory disease.